ICON

Medical Director - Neurology

Company
ICON
Location
Mannheim or Berlin, Germany, Reading, UK, Sofia, Bulgaria
Salary
Competitive
Posted
15 Jun 2021
Closes
30 Jun 2021
Ref
CH2021-78567
Hours
Full Time
Contract Type
Permanent
Experience Level
Experienced (non-manager)

PRA Health Sciences is a Clinical Research Organisation experiencing exceptional growth globally. The people we employ are key to this growth.

People don’t come to PRA to witness the future of clinical development, they come to shape it. With an average of more than 6 former employees returning to PRA each month we can confidently say that the grass is greener at PRA. Come join the movement and discover your passion, your purpose, your PRA.

We are currently looking for a Medical Director - Neurology for our Medical Affairs Department in Mannheim or Berlin, Germany / Reading, UK / Sofia, Bulgaria. 

Joining our Medical Affairs Department working in a fast-paced, client-focused global environment the Medical Director's specialist expertise is called upon throughout the entire lifecycle of a project and as such the Medical Director plays a pivotal role in our business and project teams.  Alongside Business Development the Medical Director is a key contributor in raising our business profile to ensure we are the preferred partner for our clients with support on their projects.

As well as sharing your vast medical expertise at investigator meetings, kick-off meetings, and client face-to-face meetings other responsibilities will include: 

  • Maintaining a strong consultative relationship with the client throughout the project lifecycle
  • Providing input into the creation of the protocol and other study-related documents
  • Participating in discussions with regulators, key opinion leaders, senior management and our clients
  • Delivering training to external project teams and PRA colleagues
  • Reviewing medical data on the indication, inclusion / exclusion criteria and other medical issues to ensure our overall project deliverables are achieved and patient safety priortitised
  • Collaborating with our Drug Safety teams to evaluate Serious Adverse Events and to develop Safety Management Plans, Pharmacovigilance Plans and Risk Management Plans

Locations: Mannheim or Berlin, Germany / Reading, UK / Sofia, Bulgaria